Coeliac disease: what can we learn from prospective studies about disease risk?
Stahl, Marisa; Koletzko, Sibylle; Andrén Aronsson, Carin; Lindfors, Katri; Liu, Edwin; Agardh, Daniel; Oikarinen, Sami; Lönnrot, Maria; Koreasalo, Mirva; Kurppa, Kalle; Hakola, Leena; Ahonen, Suvi; Åkerlund, Mari; Mattila, Markus; Virtanen, Suvi; Hyöty, Heikki (2023-11-13)
Stahl, Marisa
Koletzko, Sibylle
Andrén Aronsson, Carin
Lindfors, Katri
Liu, Edwin
Agardh, Daniel
Oikarinen, Sami
Lönnrot, Maria
Koreasalo, Mirva
Kurppa, Kalle
Hakola, Leena
Ahonen, Suvi
Åkerlund, Mari
Mattila, Markus
Virtanen, Suvi
Hyöty, Heikki
13.11.2023
The Lancet. Child and adolescent health
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202401111365
https://urn.fi/URN:NBN:fi:tuni-202401111365
Kuvaus
Peer reviewed
Tiivistelmä
Paediatric prospective studies of coeliac disease with longitudinal collection of biological samples and clinical data offer a unique perspective on disease risk. This Review highlights the information now available from international paediatric prospective studies on genetic and environmental risk factors for coeliac disease. In addition, recent omics studies have made it possible to study complex interactions between genetic and environmental factors and thereby further our insight into the causes of the disease. In the future, paediatric prospective studies will be able to provide more detailed risk prediction models combining genes, the environment, and biological corroboration from multiomics. Such studies could also contribute to biomarker development and an improved understanding of disease pathogenesis.
Kokoelmat
- TUNICRIS-julkaisut [22389]